Lineage Cell Therapeutics
LCTX
#8743
Rank
C$0.17 B
Marketcap
$0.77
Share price
-1.91%
Change (1 day)
-47.96%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Cash on Hand

Cash on Hand as of September 2024 : C$46.98 Million

According to Lineage Cell Therapeutics 's latest financial reports the company has C$46.98 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lineage Cell Therapeutics - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$47.07 M-40.06%
2022-12-31C$78.53 M6.33%
2021-12-31C$73.85 M39.35%
2020-12-31C$53 M33.1%
2019-12-31C$39.81 M-5.05%
2018-12-31C$41.93 M-12.63%
2017-12-31C$47.99 M57.23%
2016-12-31C$30.52 M-48.86%
2015-12-31C$59.68 M74.51%
2014-12-31C$34.2 M485.03%
2013-12-31C$5.84 M34.85%
2012-12-31C$4.33 M-80.81%
2011-12-31C$22.59 M-32.27%
2010-12-31C$33.35 M159.77%
2009-12-31C$12.84 M85488.32%
2008-12-31C$0.01 M61.06%
2007-12-31C$0 M-98.57%
2006-12-31C$0.65 M-69.41%
2005-12-31C$2.13 M42.74%
2004-12-31C$1.49 M59.1%
2003-12-31C$0.94 M-53.66%
2002-12-31C$2.02 M-22.95%
2001-12-31C$2.63 M33.3%
2000-12-31C$1.97 M-74.13%
1999-12-31C$7.63 M106.88%
1998-12-31C$3.69 M
1998-06-30C$6.03 M-43.98%
1997-06-30C$10.77 M229.17%
1996-06-30C$3.27 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.39 B 732.65%๐Ÿ‡บ๐Ÿ‡ธ USA